Editas Medicine, Inc. - EDIT

SEC FilingsOur EDIT Tweets

About Gravity Analytica

Recent News

  • 11.03.2025 - Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025
  • 10.21.2025 - Chardan 9th Annual Genetic Medicines Conference
  • 10.21.2025 - Chardan 9th Annual Genetic Medicines Conference
  • 10.14.2025 - H.C. Wainwright Genetic Medicines Virtual Conference
  • 10.14.2025 - H.C. Wainwright Genetic Medicines Virtual Conference
  • 10.09.2025 - Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
  • 10.06.2025 - Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
  • 10.06.2025 - Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
  • 10.06.2025 - Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
  • 09.04.2025 - Cantor Global Healthcare Conference

Recent Filings

  • 10.09.2025 - 8-K Current report
  • 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.02.2025 - 8-K Current report